首页> 外国专利> FORMULATION FOR TOPICAL APPLICATION TO SKIN CONTAINING GINSENOSIDE RH2 AND/OR GINSENOSIDE RG3 HAVING EXCELLENT NORMALIZING EFFECT ON CUTANEOUS IMMUNE AND CELL-ACTIVATING EFFECT

FORMULATION FOR TOPICAL APPLICATION TO SKIN CONTAINING GINSENOSIDE RH2 AND/OR GINSENOSIDE RG3 HAVING EXCELLENT NORMALIZING EFFECT ON CUTANEOUS IMMUNE AND CELL-ACTIVATING EFFECT

机译:含人参皂苷RH2和/或人参皂苷RG3的皮肤局部应用配方,对皮肤的免疫和细胞活化作用具有出色的标准化作用

摘要

PURPOSE: A formulation for topical application to human skin containing ginsenoside Rh2 and/or ginsenoside Rg3 as an effective ingredient is provided. The dermatological formulation includes drugs, quasi-drugs and cosmetics and has excellent normalizing effect on cutaneous immune and cell-activating effect. CONSTITUTION: The formulation for topical application to human skin contains 0.0001 to 10% by weight of ginsenoside Rh2 and/or ginsenoside Rg3 in the shape of solids. The formulation is selected from creams, sprays, gelling agents, emulsions or lotions. The ginsenoside Rh2 and/or ginsenoside Rg3 are obtained by extracting Panax ginseng C. A. Meyer, Panax japonicus C. A. Meyer, Panax notoginseng (Burk. ) F. H. Chen or Panax quinquefolium (American or white ginseng) after enzymatic treatment.
机译:目的:提供一种人参皂苷Rh2和/或人参皂苷Rg3作为有效成分的局部施用制剂。该皮肤病学制剂包括药物,准药物和化妆品,并且对皮肤免疫和细胞激活作用具有优异的正常化作用。组成:局部施用于人皮肤的制剂含有0.0001至10重量%的固体状人参皂苷Rh2和/或人参皂苷Rg3。该制剂选自霜剂,喷雾剂,胶凝剂,乳液或洗剂。人参皂苷Rh2和/或人参皂苷Rg3是通过酶处理后提取人参C.A.迈耶,人参三叶草C.A.迈耶,三七(Burks.F.H.Chen)或人参西洋参(美国或白参)而获得的。

著录项

  • 公开/公告号KR20040079051A

    专利类型

  • 公开/公告日2004-09-14

    原文格式PDF

  • 申请/专利权人 BIOSAPOGEN CO. LTD.;

    申请/专利号KR20030013953

  • 发明设计人 JUNG SANG SU;YOO YEONG HYO;

    申请日2003-03-06

  • 分类号A61K7/48;

  • 国家 KR

  • 入库时间 2022-08-21 22:48:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号